EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut microbiome and immune checkpoint inhibitor toxicity

Rik J Verheijden, Mick J M van Eijs, Fernanda L Paganelli, Marco C Viveen, Malbert R C Rogers, Janetta Top, Anne M May, Janneke H H M van de Wijgert, Karijn P M Suijkerbuijk, UNICIT-consortium

European Journal of Cancer · 2025-02 · 216 · 115221

DOI: 10.1016/j.ejca.2025.115221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025-02. Verfasst von Rik J Verheijden und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, PO box 85500, Utrecht 3584 CX, the Netherlands; Department of …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeImmune Checkpoint InhibitorsNeoplasmsHumansMaleFemaleMiddle AgedAgedProspective StudiesAdultRNA, Ribosomal, 16S

Stichwörter der Autor:innen

Checkpoint inhibitorImmune-related adverse eventMicrobiomeToxicity

Substanzen

Immune Checkpoint InhibitorsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, PO box 85500, Utrecht 3584 CX, the Netherlands; Department of Epidemiology and Health Economics, Julius Center for Health Sciences a…
  • Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, PO box 85500, Utrecht 3584 CX, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht Univ…
  • Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, PO box 85500, Utrecht 3584 CX, the Netherlands; Winclove Probiotics, Amsterdam, 1033JS, the Netherlands.
  • Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, PO box 85500, Utrecht 3584 CX, the Netherlands.
  • Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO box 85500, Utrecht 3584 CX, the Netherlands.
  • Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, PO box 85500, Utrecht 3584 CX, the Netherlands. Electronic address: K.Suijkerbuijk@umcutrecht.nl.

Zitieren

APA

Verheijden, R. J., van Eijs, M. J. M., Paganelli, F. L., Viveen, M. C., Rogers, M. R. C., Top, J., May, A. M., van de Wijgert, J. H. H. M., Suijkerbuijk, K. P. M., & UNICIT-consortium (2025). Gut microbiome and immune checkpoint inhibitor toxicity. European Journal of Cancer, 216, 115221. https://doi.org/10.1016/j.ejca.2025.115221

Vancouver

Verheijden RJ, van Eijs MJM, Paganelli FL, Viveen MC, Rogers MRC, Top J, et al. Gut microbiome and immune checkpoint inhibitor toxicity. European Journal of Cancer. 2025;216:115221. doi:10.1016/j.ejca.2025.115221

BibTeX
@article{Verheijden2025,
  author = {Verheijden, Rik J and van Eijs, Mick J M and Paganelli, Fernanda L and Viveen, Marco C and Rogers, Malbert R C and Top, Janetta and May, Anne M and van de Wijgert, Janneke H H M and Suijkerbuijk, Karijn P M and UNICIT-consortium, UNICIT-consortium},
  title = {Gut microbiome and immune checkpoint inhibitor toxicity},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {216},
  pages = {115221},
  doi = {10.1016/j.ejca.2025.115221}
}
Kostenlos starten →